Cargando…

The Role of Topical Brimonidine Tartrate Gel as a Novel Therapeutic Option for Persistent Facial Erythema Associated with Rosacea

Rosacea is a chronic inflammatory skin condition that commonly presents with persistent facial erythema with or without the coincident presence of flushing, telangiectasias, inflammatory papules or pustules, phymatous changes, or ocular involvement. Patients often present with a constellation of var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Andrew William, Johnson, Sandra Marchese
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580655/ https://www.ncbi.nlm.nih.gov/pubmed/26112098 http://dx.doi.org/10.1007/s13555-015-0078-1

Ejemplares similares

The role of brimonidine tartrate gel in the treatment of rosacea
por: Jackson, J Mark, et al.
Publicado: (2015)

Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability
por: Anderson, Michael S, et al.
Publicado: (2017)

The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations
por: Alonso, Ruiz Simonato, et al.
Publicado: (2020)

Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study
por: Layton, A.M., et al.
Publicado: (2015)

Preparation and Characterization of Ion-Sensitive Brimonidine Tartrate In Situ Gel for Ocular Delivery
por: Xu, Haonan, et al.
Publicado: (2023)

Fluorimetric Quantification of Brimonidine Tartrate in Eye Drops
por: Sunitha, G., et al.
Publicado: (2013)

Bilateral Lipid Keratopathy in the Setting of Brimonidine Tartrate Use
por: Moshirfar, Majid, et al.
Publicado: (2023)

Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine Therapy
por: Docherty, James R., et al.
Publicado: (2016)

Use of brimonidine tartrate to resolve telangiectatic matting: case report
por: de Mello, Brenno Augusto Seabra, et al.
Publicado: (2020)

Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study
por: Orii, Yusuke, et al.
Publicado: (2023)

Topical Brimonidine as an Effective Adjuvant to Local Anesthetics for Post Treatment Erythema and Pain Reduction
por: Kwon, Hyun Jung, et al.
Publicado: (2019)

Corneal Opacity Induced by Antiglaucoma Agents Other Than Brimonidine Tartrate
por: Kasuya, Yuka, et al.
Publicado: (2020)

Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea
por: Yang, Rongli, et al.
Publicado: (2022)

Preparation and Evaluation of Nano-vesicles of Brimonidine Tartrate as an Ocular Drug Delivery System
por: Prabhu, P, et al.
Publicado: (2010)

Augmented in vitro and in vivo Profiles of Brimonidine Tartrate Using Gelatinized-Core Liposomes
por: Abdel Azim, Engy A, et al.
Publicado: (2022)

Correction to: Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea
por: Yang, Rongli, et al.
Publicado: (2022)

Potential depressive central nervous system effects of brimonidine topical gel
por: Foschi, Cristina, et al.
Publicado: (2020)

Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study
por: Emad Eldeeb, Alaa, et al.
Publicado: (2019)

Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma
por: Dubey, Akhilesh, et al.
Publicado: (2014)

Effects of brimonidine tartrate 0.1% ophthalmic solution on the pupil, refraction, and light reflex
por: Kato, C. O. Sayaka, et al.
Publicado: (2018)

Brimonidine and timolol concentrations in the human vitreous and aqueous humors after topical instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution: An interventional study
por: Orii, Yusuke, et al.
Publicado: (2022)

Perceptions on the Psychological Impact of Facial Erythema Associated with Rosacea: Results of International Survey
por: Dirschka, Thomas, et al.
Publicado: (2015)

In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea
por: Piwnica, David, et al.
Publicado: (2018)

Effect of over-the-counter brimonidine tartrate 0.025% ophthalmic solution on pupil size in healthy adults
por: Nejad, Mitra, et al.
Publicado: (2021)

Effects of brimonidine tartrate 0.2 and 0.15% ophthalmic solution on the static and dynamic pupil characteristics
por: Yang, Jing, et al.
Publicado: (2023)

Evaluation of a simple image‐based tool to quantify facial erythema in rosacea during treatment
por: Logger, Jade G. M., et al.
Publicado: (2020)

Objectively quantifying facial erythema in rosacea aided by the ImageJ analysis of VISIA red images
por: Tao, Meng, et al.
Publicado: (2022)

Comments on: “In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea”
por: Gil, Daniel
Publicado: (2018)

A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems
por: Sun, Jianguo, et al.
Publicado: (2017)

Topical brimonidine for pyogenic granuloma after paronychia surgery
por: Chen, Yusha, et al.
Publicado: (2020)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients
por: Tsumura, Toyoaki, et al.
Publicado: (2014)

Prolonged central nervous system and respiratory depression in preterm neonates after exposure to brimonidine tartrate and timolol maleate ophthalmic drops
por: Azarcon, Corrina P., et al.
Publicado: (2020)

Novel long-acting brimonidine tartrate loaded-PCL/PVP nanofibers for versatile biomedical applications: fabrication, characterization and antimicrobial evaluation
por: Salim, Samar A., et al.
Publicado: (2023)

Resolution of rosacea-associated persistent facial edema with osteopathic manipulative treatment
por: Jay, Ryan, et al.
Publicado: (2022)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]
Publicado: (2015)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]
Publicado: (2015)

Comparisons of efficacy and safety between preserved and preservative-free brimonidine tartrate in glaucoma and ocular hypertension: a parallel-grouped, randomized trial
por: Kim, Ko Eun, et al.
Publicado: (2023)

Recurring Facial Erythema in an Infant
por: Hassan, Sam, et al.
Publicado: (2016)

Erythema of Rosacea Affects Health-Related Quality of Life: Results of a Survey Conducted in Collaboration with the National Rosacea Society
por: Baldwin, Hilary E., et al.
Publicado: (2019)

Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder
por: Rajabalaya, Rajan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_acvsh4rdon47k3qhqt41q1b4pe